Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bogen

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Protein Engineering, Design & Selection : PEDS|October 11, 2007
Functional phage display of two murine alpha/beta T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistanceG Å Løset, E Lunde, B Bogen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2001
The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccinationI B Rasmussen, E Lunde, T E Michaelsen, et al.
European Journal of Immunology|August 26, 1998
Expression level of a transgenic lambda2 chain results in isotype exclusion and commitment to B1 cellsH Engel, B Bogen, U Müller, et al.
The Journal of Frailty & Aging|May 31, 2017
The Association between Daily Walking Behavior and Self-Reported Physical Function in Community-Dwelling Older AdultsB Bogen, M K Aaslund, A H Ranhoff, et al.
Leukemia|July 11, 2015
Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrowT Matthes, B Manfroi, A Zeller, et al.
The Journal of Experimental Medicine|October 6, 1999
The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factorsM Djerbi, V Screpanti, A I Catrina, et al.
Molecular Immunology|December 1, 1996
V lambda-light chain genes reconstitute immune responses to defined carbohydrate antigens or haptens by utilizing different VH genesA Bot, A Nangpal, L Pricop, et al.
Leukemia|October 10, 2015
Idiotype-specific CD4(+) T cells eradicate disseminated myelomaO A Haabeth, A Tveita, M Fauskanger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997
Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myelomaV L Reichardt, C Y Okada, K E Stockerl-Goldstein, et al.
International Reviews of Immunology|March 14, 2002
"Troy-bodies": recombinant antibodies that target T cell epitopes to antigen presenting cellsE Lund, I B Rasmussen, K H Western, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Protein Engineering, Design & Selection : PEDS|October 11, 2007
Functional phage display of two murine alpha/beta T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistanceG Å Løset, E Lunde, B Bogen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2001
The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccinationI B Rasmussen, E Lunde, T E Michaelsen, et al.
European Journal of Immunology|August 26, 1998
Expression level of a transgenic lambda2 chain results in isotype exclusion and commitment to B1 cellsH Engel, B Bogen, U Müller, et al.
The Journal of Frailty & Aging|May 31, 2017
The Association between Daily Walking Behavior and Self-Reported Physical Function in Community-Dwelling Older AdultsB Bogen, M K Aaslund, A H Ranhoff, et al.
Leukemia|July 11, 2015
Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrowT Matthes, B Manfroi, A Zeller, et al.
The Journal of Experimental Medicine|October 6, 1999
The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factorsM Djerbi, V Screpanti, A I Catrina, et al.
Molecular Immunology|December 1, 1996
V lambda-light chain genes reconstitute immune responses to defined carbohydrate antigens or haptens by utilizing different VH genesA Bot, A Nangpal, L Pricop, et al.
Leukemia|October 10, 2015
Idiotype-specific CD4(+) T cells eradicate disseminated myelomaO A Haabeth, A Tveita, M Fauskanger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997
Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myelomaV L Reichardt, C Y Okada, K E Stockerl-Goldstein, et al.
International Reviews of Immunology|March 14, 2002
"Troy-bodies": recombinant antibodies that target T cell epitopes to antigen presenting cellsE Lund, I B Rasmussen, K H Western, et al.
Pageof 9